Amylx Pharmaceuticals Inc vs Amplitude Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Amplitude Inc trades at $12.78 (market cap $1.59B). The key difference: Amylx Pharmaceuticals Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| AMLX | AMPL | |
|---|---|---|
Market Cap | $2.64B | $1.59B |
Sector | Health | Technology |
52-Week High | $24.19 | $12.69 |
52-Week Low | $7.82 | $5.61 |
Enterprise Value | $2.39B | $1.45B |
Trailing returns across standard periods
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Amplitude Inc is pioneering a new category of software called digital optimization. The company's digital optimization system serves as the command center for businesses to connect digital products to business outcomes.
Read more on AMPL →